These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 32812494)

  • 1. Dendritic Spines: Mediators of Cognitive Resilience in Aging and Alzheimer's Disease.
    Walker CK; Herskowitz JH
    Neuroscientist; 2021 Oct; 27(5):487-505. PubMed ID: 32812494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic spine remodeling accompanies Alzheimer's disease pathology and genetic susceptibility in cognitively normal aging.
    Boros BD; Greathouse KM; Gearing M; Herskowitz JH
    Neurobiol Aging; 2019 Jan; 73():92-103. PubMed ID: 30339964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aβ mediates F-actin disassembly in dendritic spines leading to cognitive deficits in Alzheimer's disease.
    Kommaddi RP; Das D; Karunakaran S; Nanguneri S; Bapat D; Ray A; Shaw E; Bennett DA; Nair D; Ravindranath V
    J Neurosci; 2018 Jan; 38(5):1085-1099. PubMed ID: 29246925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic spines provide cognitive resilience against Alzheimer's disease.
    Boros BD; Greathouse KM; Gentry EG; Curtis KA; Birchall EL; Gearing M; Herskowitz JH
    Ann Neurol; 2017 Oct; 82(4):602-614. PubMed ID: 28921611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structure and function of actin cytoskeleton in mature glutamatergic dendritic spines.
    Bellot A; Guivernau B; Tajes M; Bosch-Morató M; Valls-Comamala V; Muñoz FJ
    Brain Res; 2014 Jul; 1573():1-16. PubMed ID: 24854120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological Strategies to Improve Dendritic Spines in Alzheimer's Disease.
    Ettcheto M; Busquets O; Cano A; Sánchez-Lopez E; Manzine PR; Espinosa-Jimenez T; Verdaguer E; Sureda FX; Olloquequi J; Castro-Torres RD; Auladell C; Folch J; Casadesús G; Camins A
    J Alzheimers Dis; 2021; 82(s1):S91-S107. PubMed ID: 33325386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the drebrin/EB3/Cdk5 pathway in dendritic spine plasticity, implications for Alzheimer's disease.
    Gordon-Weeks PR
    Brain Res Bull; 2016 Sep; 126(Pt 3):293-299. PubMed ID: 27365229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analyzing dendritic spine pathology in Alzheimer's disease: problems and opportunities.
    Dorostkar MM; Zou C; Blazquez-Llorca L; Herms J
    Acta Neuropathol; 2015 Jul; 130(1):1-19. PubMed ID: 26063233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid beta: a putative intra-spinal microtubule-depolymerizer to induce synapse-loss or dentritic spine shortening in Alzheimer's disease.
    Mitsuyama F; Futatsugi Y; Okuya M; Karagiozov K; Peev N; Kato Y; Kanno T; Sano H; Koide T
    Ital J Anat Embryol; 2009; 114(2-3):109-20. PubMed ID: 20198823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic Spine and Synaptic Plasticity in Alzheimer's Disease: A Focus on MicroRNA.
    Reza-Zaldivar EE; Hernández-Sápiens MA; Minjarez B; Gómez-Pinedo U; Sánchez-González VJ; Márquez-Aguirre AL; Canales-Aguirre AA
    Front Cell Dev Biol; 2020; 8():255. PubMed ID: 32432108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolic brain signature of cognitive resilience in the 80+: beyond Alzheimer pathologies.
    Arenaza-Urquijo EM; Przybelski SA; Lesnick TL; Graff-Radford J; Machulda MM; Knopman DS; Schwarz CG; Lowe VJ; Mielke MM; Petersen RC; Jack CR; Vemuri P
    Brain; 2019 Apr; 142(4):1134-1147. PubMed ID: 30851100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic Microtubules in Alzheimer's Disease: Association with Dendritic Spine Pathology.
    Pchitskaya EI; Zhemkov VA; Bezprozvanny IB
    Biochemistry (Mosc); 2018 Sep; 83(9):1068-1074. PubMed ID: 30472945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EphA4 loss improves social memory performance and alters dendritic spine morphology without changes in amyloid pathology in a mouse model of Alzheimer's disease.
    Poppe L; Rué L; Timmers M; Lenaerts A; Storm A; Callaerts-Vegh Z; Courtand G; de Boer A; Smolders S; Van Damme P; Van Den Bosch L; D'Hooge R; De Strooper B; Robberecht W; Lemmens R
    Alzheimers Res Ther; 2019 Dec; 11(1):102. PubMed ID: 31831046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drebrin in Alzheimer's Disease.
    Ishizuka Y; Hanamura K
    Adv Exp Med Biol; 2017; 1006():203-223. PubMed ID: 28865022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of TREM2 Confers Resilience to Synaptic and Cognitive Impairment in Aged Mice.
    Qu W; Li L
    J Neurosci; 2020 Dec; 40(50):9552-9563. PubMed ID: 33139402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel approaches to increase synaptic resilience as potential treatments for Alzheimer's disease.
    Pham AQ; Dore K
    Semin Cell Dev Biol; 2023 Apr; 139():84-92. PubMed ID: 35370089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic Spines in Alzheimer's Disease: How the Actin Cytoskeleton Contributes to Synaptic Failure.
    Pelucchi S; Stringhi R; Marcello E
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in the genetic architecture of cognitive resilience to Alzheimer's disease.
    Eissman JM; Dumitrescu L; Mahoney ER; Smith AN; Mukherjee S; Lee ML; Scollard P; Choi SE; Bush WS; Engelman CD; Lu Q; Fardo DW; Trittschuh EH; Mez J; Kaczorowski CC; Hernandez Saucedo H; Widaman KF; Buckley RF; Properzi MJ; Mormino EC; Yang HS; Harrison TM; Hedden T; Nho K; Andrews SJ; Tommet D; Hadad N; Sanders RE; Ruderfer DM; Gifford KA; Zhong X; Raghavan NS; Vardarajan BN; ; ; ; Pericak-Vance MA; Farrer LA; Wang LS; Cruchaga C; Schellenberg GD; Cox NJ; Haines JL; Keene CD; Saykin AJ; Larson EB; Sperling RA; Mayeux R; Cuccaro ML; Bennett DA; Schneider JA; Crane PK; Jefferson AL; Hohman TJ
    Brain; 2022 Jul; 145(7):2541-2554. PubMed ID: 35552371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variants and functional pathways associated with resilience to Alzheimer's disease.
    Dumitrescu L; Mahoney ER; Mukherjee S; Lee ML; Bush WS; Engelman CD; Lu Q; Fardo DW; Trittschuh EH; Mez J; Kaczorowski C; Hernandez Saucedo H; Widaman KF; Buckley R; Properzi M; Mormino E; Yang HS; Harrison T; Hedden T; Nho K; Andrews SJ; Tommet D; Hadad N; Sanders RE; Ruderfer DM; Gifford KA; Moore AM; Cambronero F; Zhong X; Raghavan NS; Vardarajan B; ; ; Pericak-Vance MA; Farrer LA; Wang LS; Cruchaga C; Schellenberg G; Cox NJ; Haines JL; Keene CD; Saykin AJ; Larson EB; Sperling RA; Mayeux R; Bennett DA; Schneider JA; Crane PK; Jefferson AL; Hohman TJ
    Brain; 2020 Aug; 143(8):2561-2575. PubMed ID: 32844198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synapses and dendritic spines as pathogenic targets in Alzheimer's disease.
    Yu W; Lu B
    Neural Plast; 2012; 2012():247150. PubMed ID: 22474602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.